Reuters logo
AstraZeneca reports positive results for gout combination therapy
August 13, 2014 / 6:23 AM / 3 years ago

AstraZeneca reports positive results for gout combination therapy

LONDON, Aug 13 (Reuters) - British drugmaker AstraZeneca said on Wednesday that test results indicated that lesinurad, a selective uric acid re-absorption inhibitor, used in combination could be a potential treatment for gout.

The company said detailed results from a series of clinical trials for the drug would be submitted to a scientific meeting later this year, and it would prepare a regulatory submission for a 200 mg dose of the drug in combination therapy.

Reporting by Paul Sandle; editing by James Davey

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below